Results 31 to 40 of about 13,588,304 (249)

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

MDL in Pattern Mining A Brief Introduction to Krimp

open access: yes, 2014
In this short paper we sketch a brief introduction to our Krimp algorithm. Moreover, we briefly discuss some of the large body of follow up research.
Glodeanu, Cynthia Vera   +6 more
core   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli   +3 more
wiley   +1 more source

Behavioral scoring model for bank customers using data envelopment analysis

open access: yes, 2015
This study proposes a behavior scoring model based on data envelopment analysis (DEA) to classify the customers into the high contribution and low contribution customers.
I-Fei Chen; Chi-Jie Lu; Tian-Shyug Lee; Chung-Ta Lee
core   +1 more source

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters   +17 more
wiley   +1 more source

Scientific and Business Cooperation in the Field of R&D: Researchers Survey, May - July, 2017

open access: yes, 2022
The purpose of the study: to find out researchers' views on the barriers to science-business collaboration in R&D and the factors that promote it. Major investigated questions: respondents were asked whether they had been involved in joint R&D projects ...
Research and Higher Education Monitoring and Analysis Centre
core  

Supporting Survivor‐Centered Care Through Digital Health Integration

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak   +15 more
wiley   +1 more source

Insight in Information: from Abstract to Anomaly

open access: yes, 2017
As a result of cheap data storage, nowadays it is not the question if a company or institution collects data or not, but rather how much they collect.
Bertens, R.   +2 more
core  

Scientific and Business Cooperation in the Field of R&D: Researchers - Leaders Survey, May - July, 2017

open access: yes, 2022
The purpose of the study: to find out the opinion of researchers - managers about the obstacles to cooperation between science and business in the field of research and development and the factors that promote it.
Research and Higher Education Monitoring and Analysis Centre
core  

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Home - About - Disclaimer - Privacy